Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update – PubMed
posted 1 month
Mashup Score: 1
PubMed - Docetaxel, abiraterone, enzalutamide, or apalutamide, each when administered with androgen deprivation therapy (ADT), represent four separate standards of care for noncastrate metastatic prostate cancer....
CP24 - Out of nearly 7,000 COVID-19 tests conducted as part of a recently launched voluntary pilot project at Toronto Pearson International Airport, 146 have come...
2.3% of over 6500 international travellers tested since Jan 7 (who required a -ve test, no symptoms before boarding) at Pearson came back +ve⁉️⁉️ That’s 1/2 the positive rate in community where ppl have symptoms or had covid contact #CloseTheBorder https://t.co/iqI8FUtK9N
Journal of Clinical Oncology - PURPOSE We report the clinical outcomes of a randomized trial comparing prophylactic whole-pelvic nodal radiotherapy to prostate-only radiotherapy (PORT) in high-risk prostate cancer. METHODS...
RT @DrMLChua: Congrats to my good friend on this important trial! @VedangMurthy https://t.co/Rd5HrYGuKV https://t.co/Rd5HrYGuKV
New York Times - In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on...
RT @theresaboyle: 'A Game Changer': Drug Brings Significant Weight Loss in Obese Patients - The New York Times https://t.co/FDgVhZIDzZ
ScienceDirect - About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By...
RT @Sushilberiwal: https://t.co/bNVlKxjYvo @bindhu2102 @AndrewKellerMD @PhilPiferRadOnc @MattHarkenrider highlights differences in two pelv…
Journal of Clinical Oncology - PURPOSE Update all preceding ASCO guidelines on initial hormonal management of noncastrate advanced, recurrent, or metastatic prostate cancer. METHODS The Expert Panel based recommendations...
It’s not Health Canada approved here but @ASCO HSPC guidelines does recommend abi/p for patients with N1/M0 high risk https://t.co/KWxXMmMIM7 https://t.co/KWxXMmMIM7
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update published this week. https://t.co/XXZJE3XnwL